Lisa Hutton
@drlh.bsky.social
Rheumatologist and physician with a special interest in GCA, PMR and osteoporosis. NHS believer. Proud mum to two great girls.
Reposted by Lisa Hutton
I learned some stuff about Bluesky I did not know by reading this.
Maybe worth passing it on to others so we can all start getting the full benefit of the 🦋.
Maybe worth passing it on to others so we can all start getting the full benefit of the 🦋.
Here’s some cool stuff you can do with Bluesky
It’s not just an Alf pics repository.
www.theverge.com
November 17, 2024 at 8:55 AM
I learned some stuff about Bluesky I did not know by reading this.
Maybe worth passing it on to others so we can all start getting the full benefit of the 🦋.
Maybe worth passing it on to others so we can all start getting the full benefit of the 🦋.
Reposted by Lisa Hutton
SELECT-GCA showing very similar promising numbers for Upadacitinib as GiACTA did for Toci.
Salient points raised re age and other risks of JAKs (well documented)
But the question always remains: does Upa have disease modifying properties in GCA? For that matter - does Toci?
#RheumSky
Salient points raised re age and other risks of JAKs (well documented)
But the question always remains: does Upa have disease modifying properties in GCA? For that matter - does Toci?
#RheumSky
November 17, 2024 at 10:49 AM
SELECT-GCA showing very similar promising numbers for Upadacitinib as GiACTA did for Toci.
Salient points raised re age and other risks of JAKs (well documented)
But the question always remains: does Upa have disease modifying properties in GCA? For that matter - does Toci?
#RheumSky
Salient points raised re age and other risks of JAKs (well documented)
But the question always remains: does Upa have disease modifying properties in GCA? For that matter - does Toci?
#RheumSky